Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries

OBJECTIVE: The CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE therapy (CHOICE) study assessed time to, and reasons for, significant treatment change after patients with type 2 diabetes (T2DM) initiated their first injectable glucose-lowering therapy (exenati...

Descripción completa

Detalles Bibliográficos
Autores principales: Östenson, Claes-Göran, Matthaei, Stephan, Reaney, Matthew, Krarup, Thure, Guerci, Bruno, Kiljanski, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Bruhn, David, Mathieu, Chantal, Theodorakis, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650573/
https://www.ncbi.nlm.nih.gov/pubmed/23667315
http://dx.doi.org/10.2147/DMSO.S41827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650573/
https://www.ncbi.nlm.nih.gov/pubmed/23667315
http://dx.doi.org/10.2147/DMSO.S41827

Ejemplares similares